- Home
- URBN vs JAZZ Comparison
URBN vs JAZZ Comparison
Compare URBN & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- URBN
- JAZZ
- Stock Information
- Founded
- URBN 1970
- JAZZ 2003
- Country
- URBN United States
- JAZZ Ireland
- Employees
- URBN N/A
- JAZZ N/A
- Industry
- URBN Clothing/Shoe/Accessory Stores
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- URBN Consumer Discretionary
- JAZZ Health Care
- Exchange
- URBN Nasdaq
- JAZZ Nasdaq
- Market Cap
- URBN 6.5B
- JAZZ 6.7B
- IPO Year
- URBN 1993
- JAZZ 2007
- Fundamental
- Price
- URBN $67.95
- JAZZ $107.51
- Analyst Decision
- URBN Buy
- JAZZ Strong Buy
- Analyst Count
- URBN 11
- JAZZ 12
- Target Price
- URBN $74.73
- JAZZ $183.08
- AVG Volume (30 Days)
- URBN 2.5M
- JAZZ 730.8K
- Earning Date
- URBN 05-21-2025
- JAZZ 07-30-2025
- Dividend Yield
- URBN N/A
- JAZZ N/A
- EPS Growth
- URBN 52.13
- JAZZ 49.21
- EPS
- URBN 4.77
- JAZZ 7.51
- Revenue
- URBN $5,679,435,000.00
- JAZZ $4,064,808,000.00
- Revenue This Year
- URBN $10.49
- JAZZ $6.05
- Revenue Next Year
- URBN $6.69
- JAZZ $4.68
- P/E Ratio
- URBN $14.20
- JAZZ $14.35
- Revenue Growth
- URBN 8.38
- JAZZ 5.76
- 52 Week Low
- URBN $33.86
- JAZZ $95.49
- 52 Week High
- URBN $75.80
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- URBN 53.25
- JAZZ 45.65
- Support Level
- URBN $67.19
- JAZZ $106.56
- Resistance Level
- URBN $71.36
- JAZZ $109.43
- Average True Range (ATR)
- URBN 2.42
- JAZZ 2.66
- MACD
- URBN -0.90
- JAZZ -0.16
- Stochastic Oscillator
- URBN 11.26
- JAZZ 12.27
About URBN Urban Outfitters Inc.
Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.